Who Owns Tylenol?

Tylenol traces its origins to 1955 when McNeil Laboratories introduced acetaminophen as a prescription pain reliever under the name Tylenol. The product was the first acetaminophen-based pain medication available in the United States, offering an alternative to aspirin and other analgesics.

In 1959, Johnson & Johnson acquired McNeil Laboratories, bringing Tylenol under its ownership. Under Johnson & Johnson's stewardship, Tylenol was converted from a prescription drug to an over-the-counter medication in 1960, dramatically expanding its market reach and accessibility.

Throughout the 1960s and 1970s, Tylenol grew to become one of America's most popular pain relief medications, known for its gentle formula and effectiveness. The brand expanded its product line to include various formulations for different needs and age groups.

The brand faced a major crisis in 1982 when seven people in Chicago died after taking Tylenol capsules that had been laced with cyanide. Johnson & Johnson's response to the crisis, including a massive product recall and introduction of tamper-resistant packaging, became a model for crisis management and product safety.

Despite the setback, Tylenol recovered and rebuilt consumer trust, returning to market leadership position. The brand has continued to innovate with new formulations, delivery methods, and expanded product lines while maintaining its reputation for safety and effectiveness.